EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Interplay between aging and metabolic diseases: from molecular mechanisms to therapeutic horizons

Dandan Zhong, Yue Sun, Lanlan Zhao, Zhenchao Hu, Guanming Li, Hao Li, Zhengwei Xie iD

Medical Review · 31.12.2025 · 5 (6) · 477-489

DOI: 10.1515/mr-2025-0047 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medical Review, online erschienen am 09.12.2025. Verfasst von Dandan Zhong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of Geriatric Precision Medicine and Aging Intervention, Xuzhou Medical University, Xuzhou, Jiangsu, China. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aging and metabolic diseases are intricately linked through bidirectional molecular mechanisms that foster a harmful cycle of physiological decline. This cycle is driven by several key factors, including altered nutrient sensing, mitochondrial dysfunction, cellular senescence, chronic inflammation, epigenetic modifications, circadian rhythm disruptions, and imbalances in the gut microbiota. Emerging interventions targeting this aging-metabolism axis hold significant promise for extending healthspan. These approaches include the use of pharmacological mimetics, senolytics, multi-omics strategies, and microbiome modulation, all of which aim to restore metabolic homeostasis and mitigate age-related pathologies. However, several challenges remain in translating these strategies into clinical practice. These include the need for tissue-specific targeting, ensuring the long-term safety of interventions, and addressing socioeconomic disparities in healthcare access. Future research efforts are focusing on integrating multi-omic technologies, organoid and human cellular models, and developing equitable precision medicine frameworks. These initiatives aim to extend healthspan and reduce the global impact of aging-related metabolic diseases.

Schlagwörter

Stichwörter der Autor:innen

agingbidirectional mechanismshealthspanmetabolic diseasestherapeutics

Autor:innen und Institutionen

  • Jiangsu Key Laboratory of Geriatric Precision Medicine and Aging Intervention, Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • Beijing Life Science Academy, Beijing, China.
  • Peking University International Cancer Institute, Health Science Center, Peking University, Beijing, China.
  • Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, USA.
  • Peking University International Cancer Institute, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.

ORCID-Profile: Zhengwei Xie

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhong, D., Sun, Y., Zhao, L., Hu, Z., Li, G., Li, H., & Xie, Z. (2025). Interplay between aging and metabolic diseases: from molecular mechanisms to therapeutic horizons. Medical Review, 5(6), 477-489. https://doi.org/10.1515/mr-2025-0047

Vancouver

Zhong D, Sun Y, Zhao L, Hu Z, Li G, Li H, et al. Interplay between aging and metabolic diseases: from molecular mechanisms to therapeutic horizons. Medical Review. 2025;5(6):477-489. doi:10.1515/mr-2025-0047

BibTeX
@article{Zhong2025,
  author = {Zhong, Dandan and Sun, Yue and Zhao, Lanlan and Hu, Zhenchao and Li, Guanming and Li, Hao and Xie, Zhengwei},
  title = {Interplay between aging and metabolic diseases: from molecular mechanisms to therapeutic horizons},
  journal = {Medical Review},
  year = {2025},
  volume = {5},
  number = {6},
  pages = {477--489},
  doi = {10.1515/mr-2025-0047}
}
Kostenlos starten →